In this episode of TOGA's Conversations in Lung Cancer Research, A/Prof Mel Moore speaks with Prof Shankar Siva about his groundbreaking work in radiation oncology, particularly focusing on the PRIME Lung study. They discuss the journey from concept to large clinical trials, the challenges of grant applications, the importance of controversial ideas in research, and the role of industry funding. Shankar also shares insights into his interest in genitourinary cancers and the future of radiation therapy, emphasising the significance of mentorship and practical advice for junior radiation oncologists.

00:00 Welcome and Introduction

00:33 Meet Professor Shankar Siva

01:26 Prime Lung Study Overview

02:32 Building on Previous Research

04:00 From Concept to Large Trial

06:11 International Collaborations

07:16 Tips for Clinician Researchers

12:11 Industry Funding in Radiation Oncology

14:33 Interest in Genitourinary Cancers

19:34 The Role of Mentorship

25:09 Advice for Junior Colleagues

28:25 Conclusion and Final Thoughts

Support TOGA

Thank you for listening to Conversations in Lung Cancer Research. If you enjoyed this episode, please rate and review us on Apple Podcasts or Spotify.

---------------

Connect with TOGA

Attend an Event: https://thoraciconcology.org.au/events/

Become a Member: Join the TOGA community at https://thoraciconcology.org.au/membership/

Donate: Support our research and treatment initiatives at https://thoraciconcology.org.au/support-us/donate/

Follow Us

LinkedIn: https://www.linkedin.com/company/thoracic-oncology-group-of-australasia/

X (Twitter): https://x.com/TOGAANZ

Instagram: https://www.instagram.com/togaanz/

YouTube:  https://www.youtube.com/@Thoracic_Oncology

---------------

Acknowledgement of Country

The Thoracic Oncology Group of Australasia Limited acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait cultures; and to Elders past and present.